PHP.L | Ticker Profile - Titan Protect

PHP.L

Primary Health Properties Plc

Real Estate · REIT - Healthcare Facilities · LSE

$90.70

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$2.4B

Total market value of the company

Trailing P/E

13.40

Reasonably valued

Forward P/E

12.26

Based on estimated future earnings — lower means cheaper

Rev Growth

+89.0%

Year-over-year revenue change

Profit Margin

45.8%

How much profit the company keeps from each dollar of revenue

ROE

6.1%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$115.00

+27% from current price — median analyst estimate

Recommendation

NONE

Consensus view from 8 analysts covering this stock

About Primary Health Properties Plc

Primary Health Properties PLC (PHP) is a UK Real Estate Investment Trust and leading investor in modern primary healthcare premises. We invest in flexible, modern properties for local primary healthcare. The overall objective of the group is to create progressive returns to shareholders through a combination of earnings growth and capital appreciation. To achieve this, PHP invests in healthcare real estate let on long-term leases, backed by secure underlying covenants where the majority of rental income is funded directly or indirectly by a government body. Primary Health Properties Plc was incorporated in 1994 in United Kingdom.

https://www.phpgroup.co.uk

Country: United Kingdom Employees: 156 Industry: REIT - Healthcare Facilities

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKUP

Price trending up with increasing momentum

Sharpe Ratio

0.177

Positive but modest risk-adjusted returns

Kelly Fraction

-0.0060

No positive edge detected — the data suggests staying out

Calmar Ratio

0.092

Drawdown risk outweighs the returns — higher risk profile

Annual Return

1.6%

Historical annualised return based on price data

Max Drawdown

-16.9%

Largest peak-to-trough decline — the worst it has been

HMM State

BULL

Statistical model sees bullish momentum

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.79

Less volatile than the market — more defensive

52W High

$109.60

17% below the year high

52W Low

$87.40

4% above the year low

Avg Volume

12,929,711

Average daily shares traded — higher means easier to buy and sell

Short Ratio

N/A

Days it would take all short sellers to cover — higher means more crowded

Short % Float

N/A

Div Yield

777.0%

Annual dividend as a percentage of the share price

EPS (TTM)

$0.07

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

129.56

Heavy leverage — higher financial risk if revenues decline

Current Ratio

0.50

Below 1 means short-term obligations exceed liquid assets — risk flag

Quick Ratio

0.36

Like current ratio but excludes inventory — stricter test

Gross Margin

89.6%

Revenue left after cost of goods — higher means pricing power

Operating Margin

81.9%

Profit from core operations before interest and tax

Free Cash Flow

$146M

Positive — the business generates more cash than it spends

Revenue (TTM)

$260M

Total revenue over the last 12 months

Net Income

$119M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$128.00

Target Median

$115.00

Target Low

$105.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go